Hi Again Friends, did you see the X Files last night ? It blew me away, the level of disclosure is unprecedented. So what’s their game ??? Do they think that most people seeing it would simply view it as fiction as usual ? The law of the universe states thet ‘they’ must divulge the truth to us so they reveal what they’re doing in the most implausible way but as far as ‘they’re concerned ‘they’ve done their bit, it’s up to us what we do with the information released. Whatever, it was music to my ears hearing everything we (bloggers etc; like myself) have been exposing for years loud and clear on a very popular TV series, even the dumbest of the dumb will have been alerted to at least one of the many disclosures, it’s gonna be a very exciting year eh.
Below is a brilliant news report by Dr Leonard Horowitz on the Zika virus, a must read, love to you all, Janie, xxx
“I think that no person would permit anybody to get close to them with an inoculation if they would really know how they are made, what they carry, what has been lied to them about them and what the real percent of danger is of contracting such a disease which is minimal.” Dr Eva Snead
Honolulu, HI—A Harvard-trained expert in emerging diseases has charged the New York Times with covering up conflicting interests and defrauding the public while purposely neglecting the most reasonable and obvious scientific explanation for how and why the brain-damaging strain of Zika virus suddenly emerged in Brazil in 2015.
Public records unearthed by whistleblower, Dr. Leonard G. Horowitz, author of the internationally acclaimed text, Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? (Tetrahedron, 1998), evidence heavy investments in an enterprise conducting experiments gone wrong using genetically-modified mosquitoes. Discoveries incriminate NYTimes billionaire owner Slim Carlos.
Horowitz_ZIKA4_Banner“The New York Times has been caught red handed concealing the emergence of the Zika virus from an experiment conducted in Brazil in 2014 using genetically-modified (GM) mosquitoes loosed by the Oxitec Company over which financial control is leveraged by Carlos’s investment bankers,” explained Dr. Horowitz.
The doctor began investigating Zika’s origin following news of the dengue fever outbreak on the Big Island where he lives. The author and filmmaker, who has been an influential voice in state and local legislative hearings regarding vaccines, learned that the State’s chief epidemiologist, Dr. Sarah Park, who Horowitz debated on PBS last year, was solicited by Oxytec agents to release GM mosquitoes without public participation in the decision. He discovered that Oxitec reported testing mutant mosquitoes as an anti-dengue experiment in Brazil.
Mosquito Experiment Oxitec
Oxytec, web intelligence showed, was largely funded by New York Times investors that continue to hold controlling interests in the Oxitech company that stands to profit from the Zika pandemic. According to company records, Oxytec manufactured the GM insects tested in Brazil in 2014, along with dengue vaccine partners in Oxford University’s ISIS innovations, also funded by BlackRock and Evercore Company private equity investors.
Slim_CarlosTimes owner Slim Carlos, is heavily invested in BlackRock, that is administered by ISIS innovations’ and Evercore officials, including Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, Bernard Taylor, co-Vice Chair for the Rockefeller JPMorgan Chase bank.
In 1947, the original Zika virus was isolated from a rhesus monkey in Uganda by Rockefeller financed researchers. The “weak virus” was then deposited with the Rockefeller Foundation, and later licensed to the American Type Culture Collection (ATCC) that sells germs to vaccine makers and bioweapons contractors worldwide.
Besides Oxitec, Carlos’s money and Taylor’s agents funded a variety of biotech companies and products including influenza, malaria, and dengue fever vaccines, and anti-viral therapeutics involving genetically modified germs.
NYTimes_Zika_articleAccording to the New York Times article (Feb. 6, 2016) “How a Medical Mystery in Brazil Led Doctors to Zika,” there are only two “leading theories” explaining the frightening outbreak. Both hypotheses date Zika’s arrival in Brazil in 2014 via travelers attending the World Cup and Va’a World Sprint canoe race in Rio de Janeiro.
But Horowitz’s “third theory” is based on science, common sense, blatent NYTimes omissions, and the fact that “[i]n April 2014, the Oxitec OX513A [GM mosquito] received technical approval for commercial release in Brazil from the National Technical Commission of Biosecurity (CTNBio),” according to company advertisements.
Oxitec reported, “a large scale release programme” carried out in Jacobina, Bahia following an earlier study there that claimed a 92% Aedes aegypti population reduction in the first area of release in Pedra Branca, Brazil.
Dengue mosquito studyIt is highly probable that the 8% of Aedes aegypti mosquitoes that survived these initial studies mated with the GM mosquitoes, causing viral mutations as warned by researchers Thavara, Tawatsin and Nagao in the journal Epidemiology and Infection (2014 Jun; 142(6): 1245-1258).
In that study, mosquito control increased cases of dengue fever (DF), and the more life threatening dengue hemorrhagic fever (DHF), in areas of high mosquito density where people had been exposed to dengue virus from earlier bites or vaccinations.
Thavara et. al., explained that more deadly virus mutations, and more severe illnesses, occurred “mainly when an individual who has acquired antibodies to one serotype is inoculated with another serotype. It was reported that mosquito control may have increased the incidence of DF and DHF due to age-dependency in manifesting these illnesses or an immunological mechanism.”
“Thavara et. al., precisely described what the world is now witnessing,” Dr. Horowitz explained. “Zika was initially reported to be a ‘weaker strain’ of the dengue virus that suddenly mutated and mysteriously emerged in Brazil after being isolated in Uganda and shipped to America. The new Zika causes never-before-seen brain damage, called microcephaly in infants. This new disease compounds the evidence and reinforces the conclusion reported by Thavara’s group; that such risky GM mosquito experiments are contraindicated in dengue exposed populations.”
The New York Times neglected this most urgent scientific intelligence, Dr. Horowitz said. “This neglect is inconsistent with Occam’s razor analysis. The simplest most obvious and scientifically sound explanation for Zika’s deadly mutation should have been known to, and reported by, the Times reporters.
This evidence of diversionary propaganda embroils Times owners, and GM mosquito vaccine enterprise investors in Oxitec. The consumer fraud in selling and concealing risky biotechnologies is a commercial crime. The deadly experiment gone awry now threatens billions of families that may birth millions of brain damaged children. The social and financial burdens from this growing pandemic are overwhelming.
Parties liable for the damages, according to Dr. Horowitz, include NYTimes major co-investors in Oxitec such as Isis Technologies, Evercore, and the BlackRock wealth management group.
Health officials internationally are urged to thoroughly consider the Thavara study, as well as Dr. Horowitz’s report on dengue fever prepared for the Hawaii County Council (viewed online at RevolutionTelevision.net).
Based on this newly acquired intelligence, dengue vaccine and GM mosquito trials should be suspended until the exploding pandemic wanes.
– end – The New York Times is largely controlled by Slim Carlos, who hold substantial investments in the BlackRock Group, the world’s largest money management firm with $3.5 trillion in assets. Mr. Carlos’s interests in GM insects and vaccines is verified by his grant of $150 million for central American disease prevention programs in alliance with the Bill and Melinda Gates Foundation.  Oxitec received its seed funding through Oxford University’s Isis Innovation corporate partnership in ISIS Technologies, “a university private commercial interest enterprise.” Isis Innovation spun off Oxitec with financing administered by Bernard Taylor, Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, and Rockefeller JPMorgan Chase co-Vice Chair. Besides Oxitec, Taylor’s agents funded a variety of biotech companies and products including influenza, malaria and dengue fever vaccines, and anti-viral therapeutics.  Ralph Schlosstein is President and Chief Executive Officer of Evercore, and was for almost twenty years was the President of BlackRock, the largest asset management firm in the world, with over $4.7 trillion of assets under management. Mr. Schlosstein co-founded BlackRock in 1988, was a director since the company went public in 1999, chaired BlackRock’s Management Committee, and served on its Executive Committee and its Investment Committee.